Over recent years, the chemical and pharmaceutical industry has seen dramatic change.
Demand for increased quality and innovation in the face of patent expiry is juxtaposed against the pressure to optimise R&D spending through cost containment and reduced time-to-market, all in an environment where the need for strict compliance to regulatory requirements has never been higher:
- Expiring patents
- R&D drivers
- New market expansion
- Globalisation
- Pricing pressures
- Regulatory compliance
To remain competitive and ensure market success, chemical and pharmaceutical companies must be able to meet these challenges in what is an increasingly complex and truly global marketplace.
Why Diagonal?
Our chemical and pharmaceutical industry expertise means that we can offer tailored, end-to-end services to help you manage the challenges unique to the pharmaceuticals industry including best practice, process improvements and benchmarking analysis.
Clients in this sector include:
- GE Healthcare
- Astra Zeneca
- Bayer
- DuPont Teijin Films
- GlaxoSmithKline
- Huntsman
- Janssen-Cilag
- Rhodia Pharma Solutions
- Unipath